Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Breast biopsy & localization · Illinois | Breast biopsy & localization · Ohio | |
|---|---|---|
| Surgeons, 2024 | 165 | 133 |
| Medicare fee-for-service cases | 9,253 | 7,179 |
| Growth since 2019 (Medicare FFS) | −2.3%/yr | −2.5%/yr |
| Forecast cases (Medicare FFS) | 9,520 in 2030 | 6,960 in 2030 |
| Forecast growth | +0.5%/yr to 2030 | −0.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.1 | 7.0 |
| Medicare Advantage share | 47% | 60% |
| Out of hospital | 8% (+2 pts since 2019) | 2% (−1 pts since 2019) |
| Cases per surgeon | 56 | 54 |
| Top 10 surgeons' share | 17% | 18% |
| Surgeons growing | 19 | 17 |
| New since the base year | 31 | 21 |
| Likely to stop billing it | 26 by 2026 | 24 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $5,568 | $2,032 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.